Widespread Internet Outage Hits Sites Using Amazon Web Services
Services disrupted included major retailers, airlines, social-media apps, financial-services companies and more. Amazon said its systems were recovering.
----
Smucker vs. Trader Joe's, Lululemon vs. Costco: Fight Over Brands Goes to Court
Frozen PB&J products square off, the latest in a long-running battle between big-name brands and retailers' private-label products.
----
Kering to Sell Creed, License Fragrance Brands to L'Oreal in $4.7 Billion Deal
The deal marks an early move by Kering's new chief, Luca de Meo, to revive the French luxury giant's fortunes.
----
Thyssenkrupp Naval-Defense Spinoff Shares Jump in Market Debut
TKMS shares started trading at 60 euros apiece, giving the business a market capitalization of $4.44 billion, but shot above that level, rising as high as 99.99 euros.
----
Getty Images Merger With Shutterstock Raises U.K. Competition Issues, Regulator Says
The image companies agreed in January to merge, creating a group valued at about $3.7 billion including debt.
----
Elon Musk Pay Drama Heats Up Ahead of Tesla Earnings
ISS, the proxy advisor, recommends shareholders vote no on a proposed massive pay package for Musk. Investors aren't likely to listen.
----
Activist Jana Takes Stake in Cooper, a Maker of Medical Devices
Bausch + Lomb is seen as a potential buyer for the contact-lens unit and the CEO said he would be interested.
----
First Ford, Now Jeep. Automakers Are Hit by Lack of Parts
Rare-earths minerals, aluminum fire, semiconductor stoppage have hit carmakers simultaneously.
----
Luxury Brands' Stiffest Competition Is the Stuff They Have Already Sold
Sales of secondhand luxury goods are growing faster than in brands' own stores.
----
FAA Lets Boeing Increase Production Cap on 737 MAX by 10%
The company can now increase production to 42 planes a month from 38, the limit put in place after a fuselage panel blew off a jet midair in January 2024.
----
FDA Approves Novo Nordisk's Rybelsus Diabetes Pill to Reduce Heart Risk
The drug, called Rybelsus, is the only oral GLP-1 medication available. It was previously approved to treat Type 2 diabetes but under the new approval, Novo Nordisk can now market the drug's benefits of reducing cardiovascular events.
----
Jefferies Shares Pare Losses After CEO Says First Brands Defrauded Bank
Rich Handler doesn't see the collapse of the auto-parts supplier as sign of broader credit issues.
----
Citgo Bidder, Auction Overseer Clash Over Fees in Disqualification Request
Gold Reserve says fees paid to advisers of the special master present a conflict of interest, while the overseer says the fees were unrelated to the Citgo sale.
----
Goldman Sachs Pursues Bigger Share of AI Infrastructure Financing Boom
A new team will focus on deals to finance data centers and other artificial-intelligence projects.
----
American Express Third-Quarter Sales Rise as Cardholders Regain Spending Confidence
Revenue climbed 11% to $18.43 billion in the quarter as consumers spent more on retail, restaurants and airlines, said the company.
(END) Dow Jones Newswires
October 20, 2025 07:00 ET (11:00 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.